COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,588 Articles (22,415 medRxiv, 8,173 bioRxiv)

Most recent first Previous |  Page 1470: Articles 14691-14700  | Next

Preclinical evaluation of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B
Liu, J., Budylowski, P., Samson, R., Griffin, B. D., Babuadze, G., Rathod, B., Colwill, K., Abioye, J. A., Schwartz, J. A., Law, R., Yip, L., Ahn, S. K., Chau, S., Naghibosadat, M., Arita, Y., Hu, Q., Yue, F. Y., Banerjee, A., Mossman, K., Mubareka, S., Kozak, R. A., Pollanen, M. S., Orozco, N. M., Gingras, A.-C., Marcusson, E. G., Ostrowski, M. A.
10.1101/2021.05.11.443286 — Posted: 2021-05-12
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard
Saeed, S., O'Brein, S. F., Abe, K., Yi, Q., Rathod, B., Wang, J., Fazel-Zarandi, M., Tuite, A., Fisman, D., Wood, H., Colwill, K., Gingras, A.-C., Drews, S.
10.1101/2021.05.11.21256992 — Posted: 2021-05-12
Methotrexate Hampers Immunogenicity to BNT162b2 mRNA COVID-19 Vaccine in Immune-Mediated Inflammatory Disease
Haberman, R. H., Herati, R., Simon, D., Samanovic, M., Blank, R. B., Tuen, M., Koralov, S., Atreya, R., Tascilar, K., Allen, J., Castillo, R., Cornelius, A., Rackoff, P., Solomon, G., Adhikari, S., Azar, N., Rosenthal, P., Izmirly, P., Samuels, J., Golden, B., Reddy, S., Neurath, M. F., Abramson, S. B., Schett, G., Mulligan, M. J., Scher, J. U.
10.1101/2021.05.11.21256917 — Posted: 2021-05-12
Characteristics of SARS-CoV-2 Positive Individuals in California From Two Periods During Notable Decline in Incident Infection
Allan-Blitz, L.-T., Turner, I., Hertlein, F., Klausner, J. D.
10.1101/2021.05.11.21257008 — Posted: 2021-05-12
Cohort-based surveillance of SARS-CoV2 transmission mirrors infection rates at the population level: a one-year longitudinal study
Klein, C., Borsche, M., Balck, A., Foeh, B., Rahmoeller, J., Peters, E., Knickmann, J., Lane, M., Vollstedt, E.-J., Elsner, S. A., Kaeding, N., Hauswaldt, S., Lange, T., Hundt, J. E., Mischnik, A., Niemann, S., Maurer, F., Homolka, S., Paulowski, L., Kramer, J., Twesten, C., Sina, C., Gillessen-Kaesbach, G., Busch, H., Ehlers, M., Taube, S., Rupp, J., Katalinic, A.
10.1101/2021.05.10.21256966 — Posted: 2021-05-12
Quantifying the potential for dominant spread of SARS-CoV-2 variant B.1.351 in the United States
Sah, P., Vilches, T. N., Shoukat, A., Pandey, A., Fitzpatrick, M. C., Moghadas, S. M., Galvani, A. P.
10.1101/2021.05.10.21256996 — Posted: 2021-05-12
Comparative sensitivity evaluation for 122 CE-marked SARS-CoV-2 antigen rapid tests
Scheiblauer, H., Filomena, A., Nitsche, A., Puyskens, A., Corman, V., Drosten, C., Zwirglmaier, K., Lange, C., Emmerich, P., Mueller, M., Knauer, O., Nuebling, M.
10.1101/2021.05.11.21257016 — Posted: 2021-05-12
Who should get vaccinated first? An effective network information-driven priority vaccination strategy
Liu, D., Tse, C. K., Chan, R. H. M., Zhan, C.
10.1101/2021.05.10.21256999 — Posted: 2021-05-12
Reinfection by the SARS-CoV-2 P.1 variant in blood donors in Manaus, Brazil
Prete, C. A., Buss, L. F., Abrahim, C. M. M., Salomon, T., Crispim, M. A. E., Oikawa, M. K., Buccheri, R., Grebe, E., da Costa, A. G., Fraiji, N. A., Carvalho, M. d. P. S. S., Alexander, N., Faria, N. R., Dye, C., Nascimento, V. H., Busch, M. P., Sabino, E. C.
10.1101/2021.05.10.21256644 — Posted: 2021-05-12
Plasmodium infection induces cross-reactive antibodies to carbohydrate epitopes on the SARS-CoV-2 Spike protein
Lapidus, S., Liu, F., Casanovas-Massana, A., Dai, Y., Huck, J. D., Lucas, C., Klein, J., Filler, R. B., Strine, M. S., Sy, M., Deme, A. B., Badiane, A. S., Dieye, B., Ndiaye, I. M., Diedhiou, Y., Mbaye, A. M., Diagne, C. T., Vigan-Womas, I., Mbengue, A., Sadio, B. D., Diagne, M. M., Moore, A. J., Mangou, K., Diallo, F., Sene, S. D., Pouye, M. N., Faye, R., Diouf, B., Nery, N., Costa, F., Reis, M., Muenker, M. C., Hodson, D. Z., Mbarga, Y., Katz, B. Z., Andrews, J. R., Campbell, M., Srivathsan, A., Kamath, K., Baum-Jones, E., Faye, O., Sall, A. A., Velez, J. C. Q., Cappello, M., Wilson, M., Ben-Mamoun, C., Some, F. A., Dabire, R. K., Moukoko, C. E. E., Ouedraogo, J. B., Boum, Y., Shon, J., Ndiaye, D., Wisnewski, A., Parikh, S., Iwasaki, A., Wilen, C. B., Ko, A. I., Ring, A. M., Bei, A. K.
10.1101/2021.05.10.21256855 — Posted: 2021-05-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).